In several kinds of hnRNPL overexpressing cancers, hnRNPL acts as an intron splicing factor that interacts with CA repeats in the 3′ untranslated region (UTR) of the Bcl-2 mRNA to prevent its degradation [33]. This evidence concerns the gene BCL2 and cancer.